Peptide-based immunotherapy in lupus: Where are we now?

By sjmartinez • October 2, 2023

P Singh R, S Bischoff D, S Singh S, H Hahn B. Peptide-based immunotherapy in lupus: Where are we now? Rheumatol Immunol Res. 2023 Sep 27;4(3):139-149. doi: 10.2478/rir-2023-0020. PMID: 37781681; PMCID: PMC10538607.

Tags: chemokine, cytokine, Geriatrics, immune tolerance, immunotherapy, lupus, peptide, Publications, regulatory T cells, Rheumatology, Veterans Administration

Dissemination, adaptation, and uptake of patient-facing materials to improve care coordination in primary care

O'Hanlon CE, Barnard JM, Rose DE, Stockdale SE, Chang ET, Yano EM, Ganz DA. Dissemination, adaptation, and uptake of patient-facing materials to improve care coordination[...]

T cell immune senescence is associated with frailty and sarcopenia in lung transplant candidates

Schaenman JM, Pickering H, Reed EF, Rossetti M, Seligman B, Weigt SS, Shino M, Sayah D, Belperio J, Hu A, Prosper A, Ruchalski K, Ardehali[...]

Is a Good Night’s Sleep One of the Keys to Successful Aging?

Ryden AM, Alessi CA. Is a Good Night's Sleep One of the Keys to Successful Aging? Sleep. 2025 Mar 24:zsaf081. doi: 10.1093/sleep/zsaf081. Epub ahead of[...]